Vitamin D3 + K2 + Magnesium: The Sunshine Stack
The D3 + K2 + magnesium stack addresses a foundational nutrition gap: vitamin D requires both K2 and magnesium to function properly in calcium metabolism and bone mineralization. D3 raises serum calcium, K2 directs it into bone rather than soft tissue, and magnesium activates the enzymes that convert D3 into its active form. Without all three, you're supplementing inefficiently, or creating imbalances.
TL;DR
- Vitamin D3 supports calcium absorption, but magnesium is required to convert it into its active hormonal form (calcitriol).
- Vitamin K2 (MK-7) activates matrix Gla-protein (MGP) and osteocalcin, directing calcium into bone and teeth instead of arteries and soft tissue.
- Magnesium is a cofactor in over 300 enzymatic reactions, including D3 metabolism and calcium regulation, deficiency limits D3 efficacy.
- Clinical doses: 5,000 IU D3 + 180-200 mcg K2 (MK-7) + 400-500 mg magnesium (glycinate or citrate) taken together with a fat-containing meal.
- Brookhaven Foundation ships this stack at research-backed doses for daily continuous use, no cycling required.
Why vitamin D3 alone is incomplete
Most people supplement vitamin D3 in isolation. Blood tests come back "normal," and the assumption is that calcium metabolism is handled. But D3 doesn't work in a vacuum.
Vitamin D3 (cholecalciferol) must undergo two hydroxylation steps to become calcitriol, the active hormone. The first occurs in the liver, the second in the kidneys, and both steps require magnesium-dependent enzymes. Without sufficient magnesium, you can supplement 10,000 IU of D3 daily and still present as functionally deficient. Uwitonze et al. 2018 demonstrated that magnesium deficiency impairs vitamin D metabolism regardless of supplementation dose.
Even if D3 is successfully converted, it increases intestinal calcium absorption. Serum calcium rises. Without vitamin K2 to regulate where that calcium goes, it deposits in arteries, kidneys, and soft tissues, the pathology behind vascular calcification. K2 activates two key proteins: matrix Gla-protein (MGP), which inhibits arterial calcification, and osteocalcin, which binds calcium into the bone matrix. Knapen et al. 2015 found that three years of MK-7 supplementation improved arterial stiffness in postmenopausal women, a direct measure of reduced vascular calcium burden.
This is the central thesis of the D3 + K2 + magnesium stack: each nutrient enables the others. D3 without magnesium stays inert. D3 without K2 raises calcium in the wrong places. K2 without D3 has less calcium to regulate. Magnesium without D3 can't fulfill its role in calcium homeostasis. The synergy is structural, not speculative.
Mechanism: how the three nutrients interact
Vitamin D3 binds to the vitamin D receptor (VDR) after conversion to calcitriol. This receptor is expressed in over 200 cell types, including intestinal epithelium, bone, immune cells, and vascular smooth muscle. Activation of the VDR increases transcription of calcium-binding proteins in the gut, raising absorption efficiency from roughly 10-15% to 30-40%. Serum calcium climbs.
Vitamin K2, specifically the menaquinone-7 (MK-7) form, carboxylates (activates) vitamin K-dependent proteins. The two most relevant to calcium metabolism are osteocalcin and MGP. Osteocalcin is secreted by osteoblasts and requires carboxylation to bind calcium ions into hydroxyapatite, the mineral matrix of bone. Undercarboxylated osteocalcin is a biomarker of poor bone mineralization and fracture risk. MGP is produced by vascular smooth muscle cells and chondrocytes; its job is to inhibit calcium deposition in soft tissue. Undercarboxylated MGP correlates with coronary artery calcification and cardiovascular mortality. Geleijnse et al. 2004 found that each 10 mcg increase in K2 intake reduced coronary heart disease risk by 9%.
Magnesium sits upstream of both pathways. It is required for the hydroxylase enzymes that convert D3 into 25-hydroxyvitamin D (in the liver) and then into 1,25-dihydroxyvitamin D or calcitriol (in the kidneys). It also regulates parathyroid hormone (PTH), which itself modulates calcium and D3 metabolism. Low magnesium leads to secondary hyperparathyroidism, PTH rises, calcium is pulled from bone, and the skeleton is cannibalized to maintain serum levels. Reddy and Edwards 2019 reviewed the bidirectional relationship: magnesium deficiency impairs D3 activation, and low D3 reduces intestinal magnesium absorption.
The result is a regulatory triad. D3 increases calcium availability. K2 directs calcium into bone and away from arteries. Magnesium enables D3 activation and prevents dysregulated calcium flux. One missing piece collapses the system.
Dosing: clinical ranges for each component
Vitamin D3: 5,000 IU daily is the standard repletion dose for adults with baseline 25(OH)D levels below 30 ng/mL. Most Americans fall into this range, particularly those living above the 37th parallel or working indoors year-round. The Endocrine Society defines sufficiency as 30-50 ng/mL, though functional medicine practitioners often target 50-70 ng/mL for immune and hormonal optimization. Holick et al. 2011 established 10,000 IU as the tolerable upper intake level (UL) with no observed adverse effects in healthy adults. We ship 5,000 IU, enough to move the needle without requiring lab monitoring.
Vitamin K2 (MK-7): 180-200 mcg daily. MK-7 is the long-chain menaquinone form with superior bioavailability and half-life compared to MK-4. It circulates for 72 hours, allowing once-daily dosing. The Rotterdam Study used 32 mcg daily and saw cardiovascular benefit, but more recent trials use 180-360 mcg to fully carboxylate osteocalcin and MGP. We dose at 200 mcg, the midpoint of the clinical range and the dose used in most bone density studies.
Magnesium: 400-500 mg elemental magnesium daily, preferably as glycinate or citrate. The RDA is 400-420 mg for men, 310-320 mg for women, but dietary intake averages 250 mg or less. Oxide and carbonate forms are poorly absorbed (4-15% bioavailability). Glycinate is chelated to the amino acid glycine, yielding 20-30% absorption and minimal GI distress. Citrate is slightly more laxative but well-tolerated at 400 mg split doses. We ship magnesium glycinate at 200 mg per serving.
Timing: all three together with a fat-containing meal. D3 and K2 are fat-soluble vitamins, absorption increases 30-50% when taken with dietary fat. Magnesium glycinate can be taken with or without food, but pairing it with D3/K2 simplifies the protocol. One dose per day, morning or evening, whichever aligns with a consistent meal.
What the stack complements and what it replaces
This stack is foundational, it supports every other protocol. It pairs well with tongkat ali + shilajit for hormonal optimization, with omega-3s for anti-inflammatory synergy, with collagen for connective tissue repair. There are no competitive pathways or nutrient antagonisms.
What it replaces: standalone D3 softgels. Calcium supplements (in most cases). If you're supplementing calcium without K2, you're feeding the calcification process. The stack provides the regulatory framework for calcium to go where it belongs, into bone, not arteries. Dietary calcium from dairy, leafy greens, and bone broth is sufficient when D3 absorption is optimized and K2 is activating osteocalcin. Unless you have diagnosed osteoporosis or are post-bariatric surgery, isolated calcium supplementation is outdated.
What to avoid stacking with: high-dose vitamin A (over 10,000 IU retinol daily), which can interfere with vitamin D signaling. Warfarin or other anticoagulants, vitamin K2 supports clotting factor synthesis and will antagonize these drugs. If you're on blood thinners, consult your prescriber before adding K2.
Brookhaven Foundation ships D3, K2, and magnesium at the doses cited in this article. The protocol is designed for daily continuous use, no cycling, no breaks. These are food-derived nutrients and cofactors, not exogenous hormones. The body does not downregulate receptors or develop tolerance. You take it every day, indefinitely, because nutritional deficiency is a chronic condition that requires chronic correction.
The 90-day marker and what happens after
Serum 25(OH)D levels stabilize after 8-12 weeks of daily D3 supplementation. Osteocalcin carboxylation improves within 6 weeks of K2 (MK-7) at clinical doses. Magnesium repletion follows a slower curve, red blood cell magnesium (a better marker than serum) normalizes over 12-16 weeks.
Subjectively, users report improved recovery, fewer muscle cramps, better sleep quality, and stable energy by week 6-8. Bone density changes require 12-24 months to show up on DEXA scans, but the metabolic shift, more calcium into bone, less into soft tissue, is happening from day one.
After 90 days, the stack becomes maintenance. You continue daily. There is no "cycle off" period. The goal is sustained sufficiency, not pharmacological peaks and troughs. This is the Brookhaven protocol: daily continuous use, dosed at the levels published research supports, for as long as you want the outcome.
Frequently asked questions
Can I take D3 + K2 + magnesium if I'm already taking a multivitamin?
Yes, but check your multivitamin's doses. Most multis contain 400-1,000 IU D3, 50-100 mcg K2, and 100-200 mg magnesium, well below clinical efficacy. The D3 + K2 + magnesium stack is designed to fill the gap between RDA minimums and functional optimization. If your multi contains 5,000 IU D3 or more, you may be doubling up, track total intake to stay below 10,000 IU daily unless working with a practitioner. K2 and magnesium have wider safety margins; toxicity is rare even at higher doses.
What's the difference between MK-4 and MK-7 forms of vitamin K2?
MK-4 is a short-chain menaquinone with a half-life of 1-2 hours, requiring multiple daily doses (15-45 mg total) to maintain blood levels. It's the form used in Japanese osteoporosis protocols. MK-7 is a long-chain menaquinone derived from natto with a half-life of 72 hours, allowing once-daily dosing at 180-200 mcg. MK-7 achieves higher and more stable serum K2 concentrations, better carboxylates osteocalcin and MGP, and is backed by more recent cardiovascular outcome data. We use MK-7 in Foundation for these reasons.
Do I need to test my vitamin D levels before starting this stack?
Testing is useful but not required to start. If your 25(OH)D level is below 30 ng/mL, 5,000 IU daily will raise it into the 40-60 ng/mL range over 8-12 weeks. If you're already above 50 ng/mL, you can dose lower or test quarterly to avoid exceeding 80-100 ng/mL (the threshold where hypercalcemia risk begins). Most adults are deficient or insufficient, so starting at 5,000 IU is reasonable. If you want precision, order a 25(OH)D test through your provider or a direct-to-consumer lab and dose accordingly. The presence of K2 and magnesium in the stack reduces the risk of D3-induced hypercalcemia.
Can magnesium cause digestive issues, and how do I avoid them?
Magnesium oxide and carbonate are poorly absorbed and draw water into the colon, causing loose stools or diarrhea at doses above 300-400 mg. Magnesium glycinate is chelated and absorbed in the small intestine with minimal laxative effect, most users tolerate 400-500 mg without issue. Citrate is mildly laxative, which some find helpful for regularity. If you're sensitive, start at 200 mg and increase by 100 mg every 5-7 days. Take with food to slow absorption. Split the dose (250 mg morning, 250 mg evening) if a single 500 mg dose causes discomfort. Glycinate remains the best-tolerated form for daily use.
Why does this stack not include calcium?
Most adults get 600-1,000 mg of dietary calcium daily from dairy, leafy greens, fortified plant milks, and bone broth. The issue is not calcium intake, it's calcium regulation. Vitamin D3 increases absorption efficiency. Vitamin K2 directs absorbed calcium into bone rather than arteries. Magnesium prevents calcium from depositing in soft tissue and supports PTH regulation. Adding isolated calcium supplements to this system often overshoots the target, raising serum calcium without improving bone density and increasing vascular calcification risk. If you have diagnosed osteoporosis or absorb calcium poorly (post-gastric bypass, severe Crohn's disease), calcium may be warranted, but pair it with K2. Otherwise, optimize what you already eat rather than supplementing more.
How does this stack compare to prescription vitamin D or bisphosphonates?
Prescription vitamin D (ergocalciferol, D2) is less effective at raising 25(OH)D than cholecalciferol (D3). Bisphosphonates (Fosamax, Boniva) inhibit osteoclast activity to slow bone resorption, they are pharmaceutical interventions for diagnosed osteoporosis. The D3 + K2 + magnesium stack is nutritional support for bone mineralization and calcium regulation in healthy adults or those with osteopenia. It does not replace medical treatment for advanced bone disease. If you're on bisphosphonates, this stack complements therapy by providing the raw materials (calcium, activated osteocalcin) for bone formation, bisphosphonates only slow breakdown. Consult your prescriber before combining.
Can I take this stack long-term without cycling off?
Yes. This is the Brookhaven position: D3, K2, and magnesium are nutrients, not drugs. The body does not develop tolerance. Vitamin D receptors do not downregulate. Magnesium stores do not "fill up" and spill over, any excess is excreted by the kidneys. K2 is used on-demand to carboxylate vitamin K-dependent proteins; there is no saturation point. The stack is designed for daily continuous use indefinitely. The 90-day frame is about seeing compounding effects, it is not a cycle. After 90 days, you continue. This is maintenance nutrition, not a pharmaceutical intervention.
What time of day should I take D3 + K2 + magnesium?
Take all three together with a fat-containing meal, morning or evening based on your schedule. Some users prefer morning to align with natural circadian vitamin D production (triggered by sunlight). Others take it with dinner because magnesium glycinate has a mild calming effect that supports sleep. Both approaches work. The key is consistency, same time daily, with dietary fat (eggs, avocado, nuts, olive oil, butter). If you take Foundation in the morning, pair it with breakfast. If evenings are more reliable, take it with dinner. Absorption is the same; adherence is what matters.
Sources
- Uwitonze AM, Razzaque MS. Role of Magnesium in Vitamin D Activation and Function. J Am Osteopath Assoc. 2018;118(3):181-189.
- Knapen MH, Braam LA, Drummen NE, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thromb Haemost. 2015;113(5):1135-1144.
- Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100-3105.
- Reddy P, Edwards LR. Magnesium Supplementation in Vitamin D Deficiency. Am J Ther. 2019;26(1):e124-e132.
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
- Schwalfenberg GK, Genuis SJ. Vitamin K2 in bone health and osteoporosis. Nat Rev Endocrinol. 2017;13(2):98-110.
- National Institutes of Health Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. Updated 2023.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
